Three-Year Follow-Up From checkMate 017/057: Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)

Affiliation auteurs!!!! Error affiliation !!!!
TitreThree-Year Follow-Up From checkMate 017/057: Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)
Type de publicationJournal Article
Year of Publication2017
AuteursFelip E, Gettinger S, Burgio MAngelo, Antonia SJ, Holgado E, Spigel D, Arrieta O, Domine M, Frontera OAren, Brahmer J, Chow LQ, Crino L, Butts C, Coudert B, Horn L, Steins M, Geese WJ, Li A, Healey D, Vokes EE
JournalASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
Volume13
Pagination142-143
Date PublishedNOV
Type of ArticleMeeting Abstract
ISSN1743-7555